Kaity Tung

573 total citations
17 papers, 423 citations indexed

About

Kaity Tung is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kaity Tung has authored 17 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kaity Tung's work include Multiple Myeloma Research and Treatments (5 papers), Immunotherapy and Immune Responses (4 papers) and RNA Interference and Gene Delivery (3 papers). Kaity Tung is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Immunotherapy and Immune Responses (4 papers) and RNA Interference and Gene Delivery (3 papers). Kaity Tung collaborates with scholars based in United States, Japan and United Kingdom. Kaity Tung's co-authors include Shin La Shu, Cheryl Allen, Marc S. Ernstoff, Edward Hurley, Hans Minderman, Yun Wu, Yunchen Yang, Suman Mukhopadhyay, David A. Foster and Graham M. Mead and has published in prestigious journals such as Blood, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Kaity Tung

16 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaity Tung United States 9 279 122 112 67 55 17 423
Gabriella Bianchino Italy 12 220 0.8× 76 0.6× 111 1.0× 41 0.6× 87 1.6× 24 429
Mark P. Ward Ireland 11 151 0.5× 104 0.9× 122 1.1× 42 0.6× 30 0.5× 24 346
Junji Shimizu Japan 7 158 0.6× 88 0.7× 87 0.8× 107 1.6× 47 0.9× 22 348
Georgios Nteliopoulos United Kingdom 12 159 0.6× 125 1.0× 155 1.4× 55 0.8× 154 2.8× 24 497
Åsa Thulin Sweden 11 203 0.7× 77 0.6× 80 0.7× 44 0.7× 60 1.1× 12 370
Yusuke Kamihara Japan 12 198 0.7× 60 0.5× 137 1.2× 39 0.6× 136 2.5× 45 465
Runzhe Chen China 14 144 0.5× 67 0.5× 241 2.2× 122 1.8× 71 1.3× 40 502
S.N. Kehlet Denmark 12 114 0.4× 100 0.8× 122 1.1× 60 0.9× 21 0.4× 17 386
Su‐Chen Lee Taiwan 13 212 0.8× 80 0.7× 97 0.9× 32 0.5× 21 0.4× 20 378
Xiaoping Xia China 12 177 0.6× 170 1.4× 160 1.4× 30 0.4× 29 0.5× 36 451

Countries citing papers authored by Kaity Tung

Since Specialization
Citations

This map shows the geographic impact of Kaity Tung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaity Tung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaity Tung more than expected).

Fields of papers citing papers by Kaity Tung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaity Tung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaity Tung. The network helps show where Kaity Tung may publish in the future.

Co-authorship network of co-authors of Kaity Tung

This figure shows the co-authorship network connecting the top 25 collaborators of Kaity Tung. A scholar is included among the top collaborators of Kaity Tung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaity Tung. Kaity Tung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wu, Rongrong, et al.. (2025). VEGFA Gene Expression in Breast Cancer Is Associated With Worse Prognosis, but Better Response to Chemotherapy and Immunotherapy. World Journal of Oncology. 16(1). 120–130. 2 indexed citations
2.
Tung, Kaity, et al.. (2025). A single-institution outcome of bronchial valve placement for persistent air leak. JTCVS Open. 26. 266–278.
3.
Tung, Kaity, et al.. (2025). Immune Checkpoint Inhibition for Hepatocellular Carcinoma, Cholangiocarcinoma, and Combined Hepatocellular-Cholangiocarcinoma. World Journal of Oncology. 16(3). 243–253. 1 indexed citations
4.
Tung, Kaity, Sai Yendamuri, & Kenneth P. Seastedt. (2024). Adoption of the Robotic Platform across Thoracic Surgeries. Journal of Clinical Medicine. 13(19). 5764–5764. 3 indexed citations
5.
6.
Tung, Kaity, Deepak Perumal, Alessandro Laganà, et al.. (2020). MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21Cip1. Oncotarget. 11(7). 727–739. 16 indexed citations
7.
Tung, Kaity, et al.. (2019). A Review of Exosomes and their Role in The Tumor Microenvironment and Host-Tumor "Macroenvironment". PubMed. 3(1). 4–8. 45 indexed citations
8.
Shu, Shin La, Yunchen Yang, Cheryl Allen, et al.. (2019). Purity and yield of melanoma exosomes are dependent on isolation method. Journal of Extracellular Vesicles. 9(1). 1692401–1692401. 134 indexed citations
9.
Cho, Hearn Jay, Kaity Tung, Deepak Perumal, et al.. (2018). MAGE-A3 Promotes Chemotherapy Resistance and Proliferation in Multiple Myeloma through Regulation of BIM and p21Cip1. Blood. 132(Supplement 1). 4464–4464. 2 indexed citations
10.
Uduman, Mohamed, Kaity Tung, Bjarne Bogen, et al.. (2017). Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model. Blood. 130. 1868–1868. 3 indexed citations
11.
Chari, Ajai, Hearn Jay Cho, Gareth J. Morgan, et al.. (2017). A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma. Blood Advances. 1(19). 1575–1583. 45 indexed citations
12.
Cho, Hearn Jay, Jami Fukui, Kaity Tung, et al.. (2016). MAGE-a Mediate Resistance to Chemotherapy in Multiple Myeloma through Regulation of Bcl-2 Proteins. Blood. 128(22). 3277–3277. 4 indexed citations
13.
Chatterjee, Amrita, Suman Mukhopadhyay, Kaity Tung, Deven Patel, & David A. Foster. (2015). Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways. Cancer Letters. 360(2). 134–140. 53 indexed citations
14.
Salloum, Darin, et al.. (2014). Mutant Ras Elevates Dependence on Serum Lipids and Creates a Synthetic Lethality for Rapamycin. Molecular Cancer Therapeutics. 13(3). 733–741. 23 indexed citations
15.
Mattes, Malcolm D., et al.. (2014). Understanding the Views of Those Who Care for Patients With Cancer on Advance Care Planning and End-of-life Care. American Journal of Hospice and Palliative Medicine®. 32(8). 802–809. 12 indexed citations
16.
Mattes, Malcolm D., Jordan Kharofa, Youssef H. Zeidan, et al.. (2013). Results of the 2012-2013 Association of Residents in Radiation Oncology (ARRO) Job Search and Career Planning Survey of Graduating Residents in the United States. International Journal of Radiation Oncology*Biology*Physics. 88(1). 25–32. 8 indexed citations
17.
Mead, Graham M., et al.. (1999). Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma. Annals of Oncology. 10(8). 943–947. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026